Search results for "neuromuscular disease"

showing 10 items of 143 documents

sj-docx-1-eso-10.1177_23969873221098582 – Supplemental material for Vascular risk factors and staging of atherosclerosis in patients and controls: Th…

2022

Supplemental material, sj-docx-1-eso-10.1177_23969873221098582 for Vascular risk factors and staging of atherosclerosis in patients and controls: The Norwegian Stroke in the Young Study by Beenish Nawaz, Annette Fromm, Halvor Øygarden, Geir Egil Eide, Sahrai Saeed, Rudy Meijer, Michiel L Bots, Kristin Modalsli Sand, Lars Thomassen, Halvor Næss and Ulrike Waje-Andreassen in European Stroke Journal

FOS: Clinical medicineCardiologyMedicine110904 Neurology and Neuromuscular Diseases
researchProduct

Cognitive correlates in amyotrophic lateral sclerosis: a population-based study in Italy.

2014

Background There is less data available regarding the characteristics of cognitive impairment in patients with amyotrophic lateral sclerosis (ALS) in a population-based series. Methodology Patients with ALS incident in Piemonte, Italy, between 2009 and 2011 underwent an extensive neuropsychological battery. Cognitive status was classified as follows: normal cognition, frontotemporal dementia (ALS-FTD), executive cognitive impairment (ALS-ECI), non-executive cognitive impairment (ALS-NECI), behavioural impairment (ALS-Bi), non-classifiable cognitive impairment. We also assessed 127 age-matched and gender-matched controls identified through patients’ general practitioners. Results Out of the …

Malemedicine.medical_specialtyPediatricsNeuromuscular diseasePopulationNeuropsychological TestsSuperoxide Dismutase-1Risk FactorsmedicineDementiaHumansEPIDEMIOLOGYAmyotrophic lateral sclerosisPsychiatryeducationCognitive reserveAgededucation.field_of_studyC9orf72 ProteinSuperoxide DismutaseDEMENTIAAmyotrophic Lateral SclerosisProteinsCognitionmedicine.diseaseSurvival AnalysisALS DEMENTIA EPIDEMIOLOGYDNA-Binding ProteinsPsychiatry and Mental healthItalyCase-Control StudiesMutationSurgeryFemaleSettore MED/26 - NeurologiaNeurology (clinical)ALSPsychologyCognition DisordersMotor neurone diseaseFrontotemporal dementia
researchProduct

sj-pdf-4-mso-10.1177_2055217320936318 - Supplemental material for Supplementary medication in multiple sclerosis: Real-world experience and potential…

2020

Supplemental material, sj-pdf-4-mso-10.1177_2055217320936318 for Supplementary medication in multiple sclerosis: Real-world experience and potential interference with neurofilament light chain measurement by Katrin Pape, Falk Steffen, Frauke Zipp and Stefan Bittner in Multiple Sclerosis Journal – Experimental, Translational and Clinical

FOS: Clinical medicine110904 Neurology and Neuromuscular DiseasesNeuroscience
researchProduct

Diagnostic immunohistochemistry in neuromuscular disorders.

2005

Most neuromuscular disorders display only non-specific myopathological features in routine histological preparations. However, a number of proteins, including sarcolemmal, sarcomeric, and nuclear proteins as well as enzymes with defects responsible for neuromuscular disorders, have been identified during the past two decades, allowing a more specific and firm diagnosis of muscle diseases. Identification of protein defects relies predominantly on immunohistochemical preparations and on Western blot analysis. While immunohistochemistry is very useful in identifying abnormal expression of primary protein abnormalities in recessive conditions, it is less helpful in detecting primary defects in …

Denervationmedicine.medical_specialtyPathologyHistologymedicine.diagnostic_testCell adhesion moleculeBlotting WesternMuscle Fibers SkeletalMuscle ProteinsAnatomical pathologyGeneral MedicineNeuromuscular DiseasesBiologyImmunohistochemistryPathology and Forensic MedicineBlotWestern blotmedicineImmunohistochemistryAnimalsHumansMuscle fibreNuclear proteinForecastingHistopathology
researchProduct

sj-docx-2-cre-10.1177_02692155231170687 - Supplemental material for Neck–Shoulder Region Training for Chronic Headache in Women: A Randomized Control…

2023

Supplemental material, sj-docx-2-cre-10.1177_02692155231170687 for Neck–Shoulder Region Training for Chronic Headache in Women: A Randomized Controlled Trial by Marjo Rinne, Sanna Garam and Katriina Kukkonen-Harjula, Kari Tokola, Arja Häkkinen, Jari Ylinen, Riku Nikander in Clinical Rehabilitation

FOS: Clinical medicine110604 Sports MedicineFOS: Health sciences110904 Neurology and Neuromuscular Diseases110314 Orthopaedics
researchProduct

Desmin-related neuromuscular disorders

1995

Desmin, the intermediate filament protein of skeletal muscle fibers, cardiac myocytes, and certain smooth muscle cells, is a member of the cytoskeleton linking Z-bands with the plasmalemma and the nucleus. The pathology of desmin in human neuromuscular disorders is always marked by increased amounts, diffusely or focally. Desmin is highly expressed in immature muscle fibers, both during fetal life and regeneration as well as in certain congenital myopathies, together with vimentin. Desmin is also enriched in neonatal myotonic dystrophy and small fibers in infantile spinal muscular atrophy. Focal accretion of desmin may be twofold, in conjunction with certain inclusion bodies, cytoplasmic an…

Pathologymedicine.medical_specialtyPhysiologyIntermediate FilamentsMuscle ProteinsVimentinmacromolecular substancesDesminCellular and Molecular NeuroscienceMuscular DiseasesPhysiology (medical)medicineHumansMyocyteIntermediate Filament ProteinMuscle SkeletalMyopathyIntermediate filamentActinInclusion BodiesbiologyNeuromuscular Diseasesbiology.proteinDesminNeurology (clinical)medicine.symptomDystrophinMuscle & Nerve
researchProduct

Jonauskaite_Tables_S1-S14_rev – Supplemental material for Universal Patterns in Color-Emotion Associations Are Further Shaped by Linguistic and Geogr…

2020

Supplemental material, Jonauskaite_Tables_S1-S14_rev for Universal Patterns in Color-Emotion Associations Are Further Shaped by Linguistic and Geographic Proximity by Domicele Jonauskaite, Ahmad Abu-Akel, Nele Dael, Daniel Oberfeld, Ahmed M. Abdel-Khalek, Abdulrahman S. Al-Rasheed, Jean-Philippe Antonietti, Victoria Bogushevskaya, Amer Chamseddine, Eka Chkonia, Violeta Corona, Eduardo Fonseca-Pedrero, Yulia A. Griber, Gina Grimshaw, Aya Ahmed Hasan, Jelena Havelka, Marco Hirnstein, Bodil S. A. Karlsson, Eric Laurent, Marjaana Lindeman, Lynn Marquardt, Philip Mefoh, Marietta Papadatou-Pastou, Alicia Pérez-Albéniz, Niloufar Pouyan, Maya Roinishvili, Lyudmyla Romanyuk, Alejandro Salgado Montej…

FOS: PsychologyFOS: Clinical medicine170199 Psychology not elsewhere classified110319 Psychiatry (incl. Psychotherapy)110904 Neurology and Neuromuscular DiseasesNeuroscience
researchProduct

Phenotypic spectrum and genomics of undiagnosed arthrogryposis multiplex congenital

2022

BackgroundArthrogryposis multiplex congenita (AMC) is characterised by congenital joint contractures in two or more body areas. AMC exhibits wide phenotypic and genetic heterogeneity. Our goals were to improve the genetic diagnosis rates of AMC, to evaluate the added value of whole exome sequencing (WES) compared with targeted exome sequencing (TES) and to identify new genes in 315 unrelated undiagnosed AMC families.MethodsSeveral genomic approaches were used including genetic mapping of disease loci in multiplex or consanguineous families, TES then WES. Sanger sequencing was performed to identify or validate variants.ResultsWe achieved disease gene identification in 52.7% of AMC index pati…

musculoskeletal diseasesArtrogriposi múltiple congènitaSettore BIO/18 - GENETICAhuman geneticsneuromuscular diseasesGenomicsBiologyCONTRACTURESCLASSIFICATIONdiseasessymbols.namesakeDiagnòsticGene mappingarthrogryposis multiplex congenitaExome SequencingOF-FUNCTION MUTATIONSGeneticsMedicine and Health SciencesgenomicsHumansGenetics (clinical)Exome sequencingArthrogryposisSanger sequencingGeneticsArthrogryposis multiplex congenitaGenetic heterogeneitySPINAL MUSCULAR-ATROPHYProteinsnervous system malformationsDYSTROPHYDisease gene identificationGENEHuman geneticsPedigreeETIOLOGYPhenotypesymbolsneuromuscularGenèticaTranscription Factors
researchProduct

sj-pdf-2-mso-10.1177_2055217320936318 - Supplemental material for Supplementary medication in multiple sclerosis: Real-world experience and potential…

2020

Supplemental material, sj-pdf-2-mso-10.1177_2055217320936318 for Supplementary medication in multiple sclerosis: Real-world experience and potential interference with neurofilament light chain measurement by Katrin Pape, Falk Steffen, Frauke Zipp and Stefan Bittner in Multiple Sclerosis Journal – Experimental, Translational and Clinical

FOS: Clinical medicine110904 Neurology and Neuromuscular DiseasesNeuroscience
researchProduct

Jonauskaite_OpenPracticesDisclosure_rev – Supplemental material for Universal Patterns in Color-Emotion Associations Are Further Shaped by Linguistic…

2020

Supplemental material, Jonauskaite_OpenPracticesDisclosure_rev for Universal Patterns in Color-Emotion Associations Are Further Shaped by Linguistic and Geographic Proximity by Domicele Jonauskaite, Ahmad Abu-Akel, Nele Dael, Daniel Oberfeld, Ahmed M. Abdel-Khalek, Abdulrahman S. Al-Rasheed, Jean-Philippe Antonietti, Victoria Bogushevskaya, Amer Chamseddine, Eka Chkonia, Violeta Corona, Eduardo Fonseca-Pedrero, Yulia A. Griber, Gina Grimshaw, Aya Ahmed Hasan, Jelena Havelka, Marco Hirnstein, Bodil S. A. Karlsson, Eric Laurent, Marjaana Lindeman, Lynn Marquardt, Philip Mefoh, Marietta Papadatou-Pastou, Alicia Pérez-Albéniz, Niloufar Pouyan, Maya Roinishvili, Lyudmyla Romanyuk, Alejandro Salg…

FOS: PsychologyFOS: Clinical medicine170199 Psychology not elsewhere classified110319 Psychiatry (incl. Psychotherapy)110904 Neurology and Neuromuscular DiseasesNeuroscience
researchProduct